Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of reagents for detecting the expression level of long-chain non-coding RNA PVT1 in the preparation of diagnostic reagents for nasopharyngeal carcinoma

A long-chain non-coding and detection reagent technology, applied in the field of detecting long-chain non-coding RNA PVT1 reagents and preparing nasopharyngeal cancer diagnostic reagents, can solve the problems that radiation cannot completely kill tumor cells, patient death, poor prognosis, etc. Clinically significant effect

Active Publication Date: 2020-07-03
THE SECOND PEOPLES HOSPITAL OF SHENZHEN +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Nasopharyngeal carcinoma is a common and high-incidence head and neck malignant tumor, prone to cervical lymph node metastasis, and the prognosis is poor. Radiation therapy is currently the main clinical treatment for nasopharyngeal carcinoma. Some patients with nasopharyngeal carcinoma have radiation resistance due to cancer cells ( Radioresistance), that is, insensitivity to radiation therapy, radiation cannot completely kill tumor cells, and the remaining tumor cells eventually recur and metastasize, leading to the death of patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of reagents for detecting the expression level of long-chain non-coding RNA PVT1 in the preparation of diagnostic reagents for nasopharyngeal carcinoma
  • Application of reagents for detecting the expression level of long-chain non-coding RNA PVT1 in the preparation of diagnostic reagents for nasopharyngeal carcinoma
  • Application of reagents for detecting the expression level of long-chain non-coding RNA PVT1 in the preparation of diagnostic reagents for nasopharyngeal carcinoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Example 1, real-time fluorescent quantitative PCR method detection confirmed that PVT1 was up-regulated in nasopharyngeal carcinoma

[0026] 1. Materials and methods:

[0027] 32 cases of normal nasopharyngeal epithelial tissues and 61 cases of nasopharyngeal carcinoma tissues were collected, total RNA was extracted, 2 μg RNA was reverse transcribed into cDNA, and real-time fluorescent quantitative PCR was performed. PVT1 forward primer is 5'-TGG CTG AGA GGG TTG AGA TC-3' as shown in SEQ NO:2, and reverse primer 5'-GCT GTA TGT GCC AAG GTC AC-3' as shown in SEQ NO:3 .

[0028] The GAPDH forward primer used for the control is 5'-ACCACAGTCCATGCCATCAC-3' as shown in SEQ NO:4, and the reverse primer 5'-TCCACCACCCTGTTGCTGTA-3' as shown in SEQ NO:5.

[0029] Real-time fluorescence quantitative PCR reaction system

[0030]

[0031] Real-time fluorescent quantitative PCR reaction steps

[0032]

[0033]

[0034]After the reaction, the amplification curve and melting...

Embodiment 2

[0037] Example 2, In situ hybridization detection found the expression of PVT1 in nasopharyngeal carcinoma, and its correlation with patient prognosis and radiotherapy sensitivity

[0038] 1. Material method

[0039] 1.1 Design and synthesis of hybridization probes

[0040] In order to detect the expression of PVT1 by in situ hybridization, we designed two groups of oligonucleotide probes for detection of PVT1 expression by in situ hybridization and three positive control in situ hybridization oligonucleotide probes.

[0041] Oligonucleotide probes for detection of PVT1 expression by in situ hybridization:

[0042] PVT1 probe 1: 5'-GGTCGGACTAGAAAACCGGTCTTCCTCTAATTTT-3' as shown in SEQ NO:6,

[0043] PVT1 probe 2: 5'-GAGACTGTAAAAACTTCTCAGGTCTTAGGA-3' as shown in SEQ NO:7,

[0044] PVT1 probe 3: 5'-CTCATAAAACTCTAACCTCTTAATTCTCGGTCAG-3' is shown in SEQ NO:8.

[0045] Positive control probe (to detect the housekeeping gene GAPDH):

[0046] GAPDH probe 1: 5'-CCACTTTACCAGAGTTAA...

Embodiment 3

[0110] Example 3, construction of shRNA vectors to interfere with the expression of PVT1

[0111] 1. Material method

[0112] 1.1 Reagents and kits

[0113] Restriction enzymes Hind III, Bgl II, EcoR I and Cla I, T4 DNA ligase, etc. were purchased from TakaRa;

[0114] TRIZOL TM Reagent (Invitrogen);

[0115] Plasmid Extraction Kit (#D6943-01, OMEGA);

[0116] Gel recovery kit (#M5212, OMEGA);

[0117] Reverse transcription kit (#A3500, Promega);

[0118] Antibiotic G418 (Ameresc).

[0119] 1.2 Design of shRNA

[0120] First, input the PVT1 sequence into Invitrogen's Block-It RNAi designer software to find the best shRNA target of the lncRNA, and select the best 3 corresponding target sequences as follows:

[0121] shRNA-1: GGACTTGAGAACTGTCCTTA as shown in SEQ NO: 12,

[0122] shRNA-2: GCTTCTCCTGTTGCTGCTAGT as shown in SEQ NO: 13,

[0123] shRNA-3: GCTCCACCCAGAAGCAATTCA shown in SEQ NO: 14,

[0124] The widely used Scramble sequence without any target in the human ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of a reagent for detecting expression quantity of lncRNA (long non-coding RNA) PVT1 in preparation of a reagent for nasopharyngeal cancer diagnosis. A PCR detection primer is designed and synthesized according to a gene sequence, and real-time fluorescent quantitative PCR verification of enlarged samples proves that expression of lncRNA PVT1 in nasopharyngealcancer is notably up-regulated, thereby proving that the detection preparation for lncRNA can be used for auxiliary diagnosis of nasopharyngeal cancer.

Description

technical field [0001] The invention belongs to the field of tumor molecular biology, and in particular relates to an application method of a reagent for detecting long-chain non-coding RNA PVT1 in the preparation of a nasopharyngeal carcinoma diagnostic reagent. Background technique [0002] Human Genome Project and its follow-up DNA Elements Encyclopedia Project (The Encyclopedia of DNAElements Project, ENCODE) research results show that protein-coding gene sequences only account for 1-3% of the human genome sequence, while most of the human genome can be transcribed The sequence is long non-coding RNA (Long non-coding RNA, lncRNA). LncRNAs widely exist in various organisms, and with the increase of biological complexity, the proportion of lncRNA sequences in the genome increases accordingly, suggesting that lncRNAs are of great significance in the process of biological evolution. As lncRNAs are continuously discovered and their functions are gradually interpreted, scient...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886C12N15/11
CPCC12Q1/6886C12Q2600/158C12Q2600/178
Inventor 聂国辉谢妮熊炜苗北平肖志强曾朝阳何奕唐艳艳魏芳杨丽婷廖前进张文玲
Owner THE SECOND PEOPLES HOSPITAL OF SHENZHEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products